Patent · US Active

Delivery of gene therapy treatments

US12397066B2 · kind B2 · utility

0Cited by
4References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 7, 2022
Grant dateAug 26, 2025
Priority date
Expiry dateAug 23, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10041
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and materials useful delivering liquids, including liquids comprising nucleic acid molecules into cells. In particular, the present invention provides methods for delivering saline solution, exogenous compositions, and isolated vectors to kidney cells, using the renal vein as a guide and under hydrodynamic pressure. The delivery methods and materials herein are useful to research, prognose, ameliorate symptoms of kidney injury, and treat kidney pathologies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.